Correlation
The correlation between ARCT and AMPH is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
ARCT vs. AMPH
Compare and contrast key facts about Arcturus Therapeutics Holdings Inc. (ARCT) and Amphastar Pharmaceuticals, Inc. (AMPH).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ARCT or AMPH.
Performance
ARCT vs. AMPH - Performance Comparison
Loading data...
Key characteristics
ARCT:
-0.91
AMPH:
-0.99
ARCT:
-1.49
AMPH:
-1.38
ARCT:
0.83
AMPH:
0.83
ARCT:
-0.73
AMPH:
-0.60
ARCT:
-1.13
AMPH:
-1.26
ARCT:
59.39%
AMPH:
30.84%
ARCT:
74.14%
AMPH:
39.69%
ARCT:
-92.79%
AMPH:
-64.63%
ARCT:
-89.87%
AMPH:
-60.45%
Fundamentals
ARCT:
$339.82M
AMPH:
$1.21B
ARCT:
-$2.52
AMPH:
$2.76
ARCT:
2.37
AMPH:
1.65
ARCT:
1.48
AMPH:
1.61
ARCT:
$135.17M
AMPH:
$728.26M
ARCT:
$136.31M
AMPH:
$365.89M
ARCT:
-$60.17M
AMPH:
$240.52M
Returns By Period
In the year-to-date period, ARCT achieves a -26.16% return, which is significantly higher than AMPH's -30.76% return.
ARCT
-26.16%
-2.19%
-31.68%
-67.44%
-14.26%
-20.29%
N/A
AMPH
-30.76%
5.33%
-43.11%
-39.00%
-11.54%
6.64%
5.00%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ARCT vs. AMPH — Risk-Adjusted Performance Rank
ARCT
AMPH
ARCT vs. AMPH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Arcturus Therapeutics Holdings Inc. (ARCT) and Amphastar Pharmaceuticals, Inc. (AMPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
ARCT vs. AMPH - Dividend Comparison
Neither ARCT nor AMPH has paid dividends to shareholders.
Drawdowns
ARCT vs. AMPH - Drawdown Comparison
The maximum ARCT drawdown since its inception was -92.79%, which is greater than AMPH's maximum drawdown of -64.63%. Use the drawdown chart below to compare losses from any high point for ARCT and AMPH.
Loading data...
Volatility
ARCT vs. AMPH - Volatility Comparison
Arcturus Therapeutics Holdings Inc. (ARCT) has a higher volatility of 22.35% compared to Amphastar Pharmaceuticals, Inc. (AMPH) at 11.45%. This indicates that ARCT's price experiences larger fluctuations and is considered to be riskier than AMPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
ARCT vs. AMPH - Financials Comparison
This section allows you to compare key financial metrics between Arcturus Therapeutics Holdings Inc. and Amphastar Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ARCT vs. AMPH - Profitability Comparison
ARCT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Arcturus Therapeutics Holdings Inc. reported a gross profit of 29.38M and revenue of 29.38M. Therefore, the gross margin over that period was 100.0%.
AMPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Amphastar Pharmaceuticals, Inc. reported a gross profit of 85.25M and revenue of 170.53M. Therefore, the gross margin over that period was 50.0%.
ARCT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Arcturus Therapeutics Holdings Inc. reported an operating income of -16.83M and revenue of 29.38M, resulting in an operating margin of -57.3%.
AMPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Amphastar Pharmaceuticals, Inc. reported an operating income of 37.29M and revenue of 170.53M, resulting in an operating margin of 21.9%.
ARCT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Arcturus Therapeutics Holdings Inc. reported a net income of -14.08M and revenue of 29.38M, resulting in a net margin of -47.9%.
AMPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Amphastar Pharmaceuticals, Inc. reported a net income of 25.29M and revenue of 170.53M, resulting in a net margin of 14.8%.